One of the possible mechanisms of resveratrol’s anticancer activity, at least in breast cancer cells, is its ability to induce the expression of SERCA3 gene fundamental for maintaining the intracellular (Ca2+) homeostasis, which results in a decreased breast cancer cell viability and triggered apoptosis [131]. This evidence concerns the gene ATP2A3 and breast carcinoma.